Sequana Medical
Sequana Medical, a Swiss-Belgian medical device company , developed an implantable pump named alfapump.[1]. The company was founded in 2006, in Switzerland by Noel Johnson[2] who remained CEO until in 2016 Ian Crosbie succeeded him[3].
In 2018 the company moved it headquarters to Ghent, Belgium[4]
alfapump[edit]
This bio-technology is a new treatment for refractory or recurrent ascites[5]. This fully implantable, programmable, wirelessly-charged, battery-powered system is an innovative treatment for for the management of fluid overload in liver disease, malignant ascites and heart failure. The system automatically and continually collects ascites and moves this to the bladder where it is passed naturally from the body[6].
This device leads to a higher quality of life for the patients[7] as the devices significantly reduces or eliminates the need for LVP (Large volume paracentesis)[8].
History[edit]
The concept of the alfapump was created in 2000 and the first prototypes were built in 2005. Later in 2008, the first patient received its alfapump. After the commercial launch of alfapump in 2012 at the EASL meeting the company started DSR (Direct Sodium Removal) trials. This is a new therapy in development for treatment of volume overload in patients suffering from heart failure, in collaboration with DR Jeffrey Testani, Associate Professor at Yale university.[9]
In 2011 and 2012 the alfapump received the CE-mark for the removal of refractory ascites due to liver cirrhosis following completion of the PIONEER clinical study and the CE-mark for removal of malignant ascites.[10]
In 2020 the alfapump is available in Germany, France, Switzerland and the united Kingdom [11].Currently, as announced in January 2019, the alfapump received the breakthrough device designation from the FDA [12].This fast tracks their track to receive FDA-approval and commercial launch in the USA[13]
- ↑ "Home". alfapump. Sequana Medical. Retrieved 2020-07-30.
- ↑ "Sequana Medical". Crunchbase. Retrieved 2020-07-30.
- ↑ "Executive Team". Sequana Medical. Sequana Medical. Retrieved 2020-07-30.
- ↑ "Buitenlandse Biotech komt naar België". De Tijd.
- ↑ "Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study) (POSEIDON)". Clinical trials. Retrieved 2020-07-30.
- ↑ "The alfapump system" (PDF). vingmed. Sequana Medical. Retrieved 2020-07-30.
- ↑ "Alfapump - New ascites treatment for more quality of life". Youtube. alfapump. Retrieved 2020-07-30.
- ↑ "The alfapump system" (PDF). vingmed. Sequana Medical. Retrieved 2020-07-30.
- ↑ "Our History". Sequana Medical. Sequana Medical.
- ↑ "Our History". Sequana Medical. Sequana Medical.
- ↑ "Where to find alfapump". alfapump. Retrieved 2020-07-30.
- ↑ "Sequana Medical receives breakthrough device designation from the fda for its alfapump". Newton Biocapital. Retrieved 2020-07-30.
- ↑ "Gents biotechbedrijf krijgt voorkeursbehandeling in VS". De Tijd. Retrieved 2020-07-30.
References[edit]
This article "Sequana Medical" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Sequana Medical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
